Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01851356 · ClinicalTrials.gov registry record
Brain Inflammation in Major Depressive Disorder Background
A clinical trial, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- 61
- Enrollment target
NCT01851356: Completed study, sponsored by National Institute of Mental Health (NIMH).
NCT01851356 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 61 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01851356 has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- 61 participants
- Enrollment target
Study Summary
Background: \- Studies have shown that inflammation plays an important role in depression. Brain inflammation may contribute to depression, and may make it more difficult to treat some kinds of depression with current therapies. Researchers want to use magnetic resonance imaging (MRI) and positron emission tomography (PET) scanning to study inflammation in the brain. To do so, they will use a contrast agent, which is a chemical that can show inflammation during an imaging study. Objectives: \- To see if people with major depressive disorder have increased inflammation in the brain. Eligibility: \- Individuals at least 18 years of age who have major depressive disorder. Design: * Participants will be screened with a physical exam and medical history. They will provide blood samples before the scanning sessions. * Participants will have a PET scan after the screening visit. They will have a dose of the contrast agent before the study. This scan will look for possible brain inflammation. * Participants will also have an MRI scan. This scan will take pictures of the brain for comparison studies. * Treatment will not be provided as part of this study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2013-05-08 |
| Est. Completion | 2018-03-22 |
What the finished NCT01851356 record still lists
NCT01851356 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 61 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01851356 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01851356 about?
NCT01851356 is a clinical study titled "Brain Inflammation in Major Depressive Disorder Background". Background: \- Studies have shown that inflammation plays an important role in depression. Brain inflammation may contribute to depression, and may make it more difficult to treat some kinds of depression with current therapies. Researchers want to use magnetic resonance imaging (MRI) and positron ...
What is the current status of trial NCT01851356?
This trial is currently completed. The enrollment target is 61 participants. The study started on 2013-05-08. Estimated completion is 2018-03-22.
Who is sponsoring clinical trial NCT01851356?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI